hotspot -WSS

hotspot

author：explore 2025-09-27 18:53:46 - browse：62

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： STAT Readout Newsletter: Today's biggest biotech updates

hotspot

WSS

Doctor appointment wait times are getting worse

CEOs share strategies for surviving biotech slump

Why health workers in Gaza are injured or die at high rates

Beam Therapeutics to lay off 20% of its staff, re

Can food be medicine? And other questions about a new push

Why is France rioting? What to know about the fatal police shooting of Nahel M

hotspot

hotspot

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Will Ozempic

Moonlake's readout produced a cash windfall. Risks remain

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

After affirmative action ruling, medical educators look to 'holistic review'

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Malaria cases in Florida and Texas: Here’s what you need to know

Doctor appointment wait times are getting worse

After affirmative action ruling, medical educators look to 'holistic review'

Lawmakers consider Medicare pay reforms for doctors

knowledge

Impact of Dobbs ruling felt at reproductive medicine meeting

4th of July breaks record for highest global temperature ever measured

Grail is spending more than ever lobbying Congress

Why health workers in Gaza are injured or die at high rates

STAT Summit: Michael J. Fox on progress in Parkinson's research

Brain 'hot spot' may explain why African Americans feel greater pain

focus

hotspot

hotspot

entertainment